CytoMed Therapeutics Limited (GDTC)

CytoMed Therapeutics Revenue

In the year 2025, CytoMed Therapeutics had annual revenue of 860.85K SGD with 71.02% growth. CytoMed Therapeutics had revenue of 410.16K in the half year ending December 31, 2025, with 83.51% growth.

• Revenue (ttm): 860.85K SGD
• Revenue Growth: +71.02%
• P/S Ratio: 22.81
• Revenue / Employee: 20,496 SGD
• Employees: 42
• Market Cap: 15.26M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	860.85K	357.48K	71.02%
Dec 31, 2024	503.37K	-4.36K	-0.86%
Dec 31, 2023	507.74K	143.82K	39.52%
Dec 31, 2022	363.91K	250.07K	219.67%
Dec 31, 2021	113.84K	54.37K	91.43%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 5, 2026

Data Sources Report a data error